Autores
Ticiana De Francesco, Manjool Shah, Jason Bacharach e Oluwatosin Smith.
Abstract
The treatment paradigm for glaucoma is beginning to shift from a predominantly reactive approach, which relies heavily on topical medications, toward a more proactive strategy that incorporates procedural interventions.
This evolution toward interventional glaucoma has been facilitated by the growing availability of lower-risk minimally invasive procedures, including laser trabeculoplasty, minimally invasive glaucoma surgery, and procedural pharmaceuticals.
A common feature of these glaucoma interventions, as with all glaucoma treatment strategies, is the need for early, prompt, and accurate diagnosis.
This review summarizes recent and emerging developments in glaucoma diagnostics. These advances include technologies and techniques for home-based intraocular pressure measurement, novel visual field platforms, photography- and optical coherence tomography-based visualization, and applications of artificial intelligence.
The review also discusses emerging technologies such as mitochondrial flavoprotein fluorescence imaging, detection of apoptosing retinal cells, visualization of collector channels, and genetic testing.
These diagnostic modalities have the potential to overcome some of the limitations associated with traditional diagnostic methods.
By increasing the frequency and feasibility of obtaining clinically valuable glaucoma data, while enabling more rapid detection of disease and progression, these emerging diagnostic technologies may facilitate a more proactive and interventional approach to glaucoma treatment.
Ultimately, the integration of advanced diagnostic technologies into clinical practice has the potential to improve disease monitoring, guide treatment decisions, and contribute to better patient care.